Laurent Massias - Concepedia

Author

Laurent Massias

Hôpital Bichat-Claude-Bernard

Also Known As

Estelle Marcault, L Massias, L. Massias, Laurent Massias, Loïc Massias, Olivier Tenaillon

109

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Hôpital Bichat-Claude-Bernard Université Paris Cité Assistance Publique – Hôpitaux de Paris Inserm Délégation Paris 7

About

Laurent Massias is an author at Hôpital Bichat-Claude-Bernard specializing in medicine, antimicrobial resistance, and antibiotics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	25	1.1K
2	Health Sciences	13	14	502
3	Biochemistry	2	2	58
4	Engineering	1	1	12
5	Allergy	1	1	12

Laurent Massias

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Controlled release of vancomycin from Poloxamer 407 gels Marie-Laure Veyries, Guy Couarraze, Sandrine Geiger, International Journal of Pharmaceutics AntibioticsMedicinePoloxamer 407Antimicrobial ChemotherapyPharmacology	1999	194
Ciprofloxacin Dosage and Emergence of Resistance in Human Commensal Bacteria B. Fantin, Xavier Duval, Laurent Massias, The Journal of Infectious Diseases	2009	119
Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations L. Musset, Olivier Bouchaud, Sophie Matheron, Microbes and Infection Plasmodium FalciparumGeneticsMalariaMolecular BiologyClinical Atovaquone-proguanil Resistance	2006	113
Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25 mg/kg total body weight regimen Étienne de Montmollin, Lila Bouadma, Nathalie Gault, Intensive Care Medicine Critical Care ManagementCritical Care MedicineIll PatientsMg/kg Total BodyElectrolyte Disorder	2014	112
Adjunctive Rifampin Is Crucial to Optimizing Daptomycin Efficacy against Rabbit Prosthetic Joint Infection Due to Methicillin-Resistant Staphylococcus aureus Azzam Saleh‐Mghir, Claudette Muller‐Serieys, Aurélien Dinh, Antimicrobial Agents and Chemotherapy	2011	97
Dose Dependence of Emergence of Resistance to Linezolid in<i>Enterococcus faecalis</i>In Vivo Nadège Bourgeois‐Nicolaos, Laurent Massias, Brigitte Couson, The Journal of Infectious Diseases	2007	85
Impact of Low-Level Resistance to Fluoroquinolones Due to <i>qnrA1</i> and <i>qnrS1</i> Genes or a <i>gyrA</i> Mutation on Ciprofloxacin Bactericidal Activity in a Murine Model of <i>Escherichia coli</i> Urinary Tract Infection Nicolas Allou, Emmanuelle Cambau, Laurent Massias, Antimicrobial Agents and Chemotherapy Bactericidal ActivityLow-level ResistanceAntimicrobial ChemotherapyAntibiotic ResistanceBacterial Pathogens	2009	77
Investigation of the Potential Role of Enterococcus faecalis in the Pathophysiology of Experimental Peritonitis Philippe Montravers, Antoine Andremont, Laurent Massias, The Journal of Infectious Diseases	1994	73
Activity and Diffusion of Tigecycline (GAR-936) in Experimental Enterococcal Endocarditis A. Lefort, Matthieu Lafaurie, Laurent Massias, Antimicrobial Agents and Chemotherapy Experimental Enterococcal EndocarditisAntimicrobial SusceptibilityHealth SciencesMedicineProlonged Half-life	2002	70
Breakthrough invasive mould infections in patients treated with caspofungin Katy-Anna Phai Pang, C. Godet, Arnaud Fekkar, Journal of Infection Mold ControlClinical MicrobiologyAntifungal AgentInfection Control	2011	68

Page 1